SB 201823-A

TargetMol
Product Code: TAR-T28668
Supplier: TargetMol
CodeSizePrice
TAR-T28668-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28668-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28668-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
SB 201823-A is a Ca2+ channel antagonist.
CAS:
141429-64-3
Formula:
C18H28Cl3NO
Molecular Weight:
380.78
Purity:
0.98
SMILES:
Cl.CCCCCN1CCC(CCOc2ccc(Cl)c(Cl)c2)CC1

References

1. Hicks CA, Ward MA, O'Neill MJ. Neuroprotective effects of the neuronal Ca(2+) channel blockers, LY042826 and LY393615 in vivo. Eur J Pharmacol. 2000 Nov 24;408(3):241-8. PubMed PMID: 11090640. 2. O'Neill MJ, Bath CP, Dell CP, Hicks CA, Gilmore J, Ambler SJ, Ward MA, Bleakman D. Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo. Eur J Pharmacol. 1997 Aug 6;332(2):121-31. PubMed PMID: 9286613. 3. Barone FC, Lysko PG, Price WJ, Feuerstein G, al-Baracanji KA, Benham CD, Harrison DC, Harries MH, Bailey SJ, Hunter AJ. SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice. Stroke. 1995 Sep;26(9):1683-9; discussion 1689-90. PubMed PMID: 7660415. 4. Benham CD, Brown TH, Cooper DG, Evans ML, Harries MH, Herdon HJ, Meakin JE, Murkitt KL, Patel SR, Roberts JC, et al. SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia. Neuropharmacology. 1993 Nov;32(11):1249-57. PubMed PMID: 8107976.